BU-NOT-SET

CONTACT US
COVID-19: a year of unprecedented change
  • Industry trends
Eyes
Insight
Oral solids: market and technology trends
  • Drug product
Eyes
Insight
Oral modified release
  • Drug product
Granules
Fact sheet
Semi-solids an overview of current regulatory requirement
  • Drug product
Tube cream
Fact sheet
API relocation strategies for CDMO’s
  • Drug substance
Eyes
Insight
Clinical trial material
  • Drug product
  • Manufacturing
hand scooping pills
Fact sheet
Time and cost-effective solubility improvement
  • Drug substance
Eyes
Insight
Dosage form development trends and technologies
  • Drug product
Eyes
Insight
Vaccine Development and Manufacturing
  • Drug product
  • Manufacturing
Eyes
Insight
Insight
  • Drug product
Guidance for start-ups on drug development
White paper
  • Drug product
  • Drug substance
Drug development for start-ups
Insight
  • Sustainability
Optimising environmental sustainability
Insight
  • Industry trends
Adapting to deal with the COVID-19 pandemic
Insight
  • Sustainability
On Drug Delivery – Sustainability Q&A
Insight
  • Analytical chemistry
Optimising analytical chemistry to improve speed to market
Insight
  • Corporate
The Recipharm Journey
Fact sheet
  • Drug substance
Solubility enhancement
Insight
  • Manufacturing
Unlocking the key changes to Annex 1